News about Macular degeneration

Dr. Javier Zarranz-Ventura receives the EURETINA Retinal Medicine Clinical Research Award 2024

Dr. Javier Zarranz-Ventura, ophthalmologist at the Clínic and researcher in the IDIBAPS Ocular Inflammation: Clinical and Experimental Studies group,1

Clínic Barcelona

Research January 4 2024

Characterizing neovascular lesions on the macula allows us to predict the response to treatment in patients with AMD

A study coordinated by researchers at the Hospital Clínic-IDIBAPS reveals that characterizing the type of neovascular lesion in the eye of patients w1

Clínic Barcelona

Health Topics October 16 2023

6 things you didn't know about Age-Related Macular Degeneration

Age-Related Macular Degeneration is, of course, related to age. However, studies show it is possible to reduce the risk of having (or delaying) this1

Clínic Barcelona

Health Topics February 5 2021

New regimen for the treatment of macular degeneration proves to be effective and reduces pressure on the health system

A study carried out at Hospital Clínic has proven the clinical effectiveness of a new protocolised treatment regimen for age-related macular degenera1

Clínic Barcelona

Health Topics June 18 2019

The eyes: excellent candidates for stem cell therapies

Replacing the cells of a damaged tissue with healthy ones using stem cells is now a reality. In the case of the eyes, the use of these new therapies1

News about Macular degeneration

Dr. Javier Zarranz-Ventura receives the EURETINA Retinal Medicine Clinical Research Award 2024

Characterizing neovascular lesions on the macula allows us to predict the response to treatment in patients with AMD

6 things you didn't know about Age-Related Macular Degeneration

New regimen for the treatment of macular degeneration proves to be effective and reduces pressure on the health system

The eyes: excellent candidates for stem cell therapies

Subscribe to the Newsletter of Clínic